| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |